Relationship of some hepatic actions of insulin to the intracellular level of cyclic adenylate.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005934:Glucagon / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005943:Gluconeogenesis / Q000187:drug effects; D005947:Glucose / Q000096:biosynthesis; D006003:Glycogen / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D007657:Ketone Bodies / Q000096:biosynthesis; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D011188:Potassium / Q000378:metabolism; D051381:Rats; D014508:Urea / Q000096:biosynthesis
D002247:Carbon Isotopes; D007328:Insulin; D007657:Ketone Bodies; D002110:Caffeine; D014508:Urea; D006003:Glycogen; D005934:Glucagon; D000242:Cyclic AMP; D005947:Glucose; D011188:Potassium; D004837:Epinephrine